Katarzyna Poznańska-Kurowska

Dr. Katarzyna Poznańska-Kurowska

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2025 in Sports
Verified
Journal Article
Open access
PDF file
Waleed Aman Ur RahmanWaleed Aman Ur Rahman
Waleed Aman Ur Rahman
Mohamad Mahdi MortadaMohamad Mahdi Mortada
Mohamad Mahdi Mortada
PŚPaulina Ślimok
Paulina Ślimok
ASAlaa Sherri
Alaa Sherri
KPKatarzyna Poznańska-Kurowska
Katarzyna Poznańska-Kurowska
Marcin KurowskiMarcin Kurowski
Marcin Kurowski
The benefits of regular physical exercise, primarily moderate-intensity exercise, are widely known, recognized, and acclaimed. As an important lifestyle modification, regular training activities are gaining increasing popularity in the general population. Apart from the obvious benefits, physical exercise may carry the risk of trauma, cardiovascular events, and exercise-induced asthma and bronchoconstriction, to name just a few well-known clinical situations reported in athletes, both recreational and competitive. In susceptible individuals, acute bouts of exercise may lead to the appearance of urticaria, angioedema, and anaphylaxis. Among these three clinical phenomena, angioedema is the least addressed and recognized, often being considered an accompanying clinical feature of urticaria or a hallmark of imminent anaphylactic reaction. To fill this knowledge gap, in this review, we focus on exercise-associated angioedema symptoms and highlight their most important features, both as isolated phenomena and in association with urticaria or anaphylaxis.

12 August 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
Michał NiedźwiedźMichał Niedźwiedź
Michał Niedźwiedź
MSMalgorzata Skibinska
Malgorzata Skibinska
Marcin KurowskiMarcin Kurowski
Marcin Kurowski
KPKatarzyna Poznańska-Kurowska
Katarzyna Poznańska-Kurowska
Incontinentia pigmenti (IP) is a rare, X-linked dominant genodermatosis caused by mutations in the IKBKG gene and characterized by sequential cutaneous stages following the lines of Blaschko. The highly inflammatory initial vesiculobullous stage frequently mimics severe neonatal infections, such as herpes simplex or bullous impetigo, leading to potentially dangerous diagnostic delays and unnecessary antimicrobial therapies. The objective of this report is to highlight the utility of multimodal medical imaging and clinico-pathologic correlation in the rapid diagnosis of early-stage IP. We present the case of a full-term female neonate presenting on the third day of life with a rapidly disseminating blistering eruption, initially treated as a widespread infectious process. A multimodal diagnostic approach was applied, incorporating bedside clinico-dermoscopic evaluation of the infant and her mother (who reported a history of early miscarriages), followed by neonatal skin biopsy, immunohistochemistry (S-100, MART-1), and subsequent genetic testing. Dermoscopy of the neonate’s transitional lesions revealed early dermal melanophage accumulation, while maternal evaluation exposed pathognomonic residual Blaschko-linear dyspigmentation featuring a distinct “pepper-like” dermoscopic pattern. Histopathology demonstrated classic eosinophilic spongiosis, intraepidermal vesicles, and early pigment incontinence. Genetic testing confirmed recurrent IKBKG exon 4–10 deletion. Crucially, this rapid diagnosis facilitated immediate targeted ophthalmologic screening, detecting asymptomatic stage 2B retinal vasculopathy. Integrating noninvasive dermoscopy with precise histopathologic correlation offers a rapid, highly effective framework to distinguish early IP from neonatal blistering infections. Timely multimodal imaging is crucial for triggering immediate multidisciplinary screening, effectively preventing severe, irreversible vision-threatening complications.

1 October 2026 in Biologics: Targets and Therapy
Verified
Journal Article
Open access
PDF file
KZKamila Zawadzińska-Halat
Kamila Zawadzińska-Halat
MSMagdalena Stec
Magdalena Stec
KPKatarzyna Poznańska-Kurowska
Katarzyna Poznańska-Kurowska
MPMaciej Pastuszczak
Maciej Pastuszczak
Netherton syndrome is a rare and severe genodermatosis caused by pathogenic variants in SPINK 5, leading to epidermal barrier dysfunction, immune dysregulation, and prominent atopic manifestations. Therapeutic options remain limited, and long-term real-world data on biologic treatment are scarce. We report a retrospective two-center real-world case series of six patients with Netherton syndrome treated with dupilumab, with emphasis on long-term outcomes, safety, and clinical effects beyond eczema control. Five patients were managed at one dermatology referral center and one patient at a second center. Clinical data were collected retrospectively from medical records, including disease severity scores, pruritus, quality of life, genetic findings, comorbidities, treatment duration, adverse events, and additional clinically relevant observations. Dupilumab was initiated because of severe, chronic, and refractory inflammatory skin disease with intense pruritus and impaired quality of life. Follow-up ranged from 13 to 34 months. All patients achieved sustained, clinically meaningful improvement in inflammatory skin lesions, pruritus, and quality of life, although complete remission was not observed. Treatment was well tolerated, including in patients with recurrent infections, immunodeficiency-like features, severe food allergy, and a history of acute lymphoblastic leukemia. Additional observations included improvement in hair abnormalities and sweating in selected patients, reduced infectious burden, improved growth parameters, and absence of further anaphylactic episodes in one patient. These findings suggest that dupilumab may represent a valuable long-term therapeutic option for Netherton syndrome with prominent type 2 inflammatory features. Potential benefits beyond eczema control should be regarded as hypothesis-generating and require confirmation in larger multicenter studies.

Verified
Journal Article
Open access
PDF file
KPKatarzyna Poznańska-Kurowska
Katarzyna Poznańska-Kurowska
MSMalgorzata Skibinska
Malgorzata Skibinska
DLDorota Lorenz
Dorota Lorenz
Waleed Aman Ur RahmanWaleed Aman Ur Rahman
Waleed Aman Ur Rahman
Marcin KurowskiMarcin Kurowski
Marcin Kurowski
Angioedema (AE) is a frequent symptom reported by dermatologists and allergists, as well as by general practitioners and physicians in other specialties. Hereditary angioedema (HAE) is an ultra-rare condition, whereas the majority of AE episodes in daily medical practice are secondary to an underlying condition or drug intake. This review discusses the most common causes of acquired angioedema, presents selected aspects of its pathogenesis in the context of available diagnostic tests, and provides an account of reports on possible management options. Acquired angioedema (AAE) poses an actual challenge both in terms of its diagnosis and management. Its variable etiology warrants a diagnostic approach aimed at the exclusion of underlying cancers, lympho- and myeloproliferative diseases, monoclonal gammopathies, as well as autoimmune and infectious conditions. Apart from its variable etiology, the management of AAE is further complicated by the lack of approved and standardized prophylaxis and treatment schemes. Therefore, an appropriate diagnostic approach is required for the efficient prevention of AAE symptoms and the detection of possible underlying pathologies.

Verified
Journal Article
Open access
PDF file
NKNikodem Kuczyński
Nikodem Kuczyński
BSBartłomiej Szewczyk
Bartłomiej Szewczyk
Michał NiedźwiedźMichał Niedźwiedź
Michał Niedźwiedź
Marcin KurowskiMarcin Kurowski
Marcin Kurowski
KPKatarzyna Poznańska-Kurowska
Katarzyna Poznańska-Kurowska
Implant-related metal hypersensitivity (MH) after total joint arthroplasty (TJA) is an uncommon and diagnostically challenging complication in which antigen-specific T-cell responses may coexist with nonspecific inflammatory reactions to wear and corrosion products. This narrative review critically summarizes current evidence on the molecular immunopathogenesis, clinical presentation, diagnosis, and management of suspected MH, with particular emphasis on HLA-associated susceptibility and the 2023 European Academy of Allergy and Clinical Immunology (EAACI) mechanistic nomenclature. A structured search of PubMed, Scopus, and Web of Science was used to identify relevant clinical, immunological, and consensus literature. Metal sensitization is substantially more common than clinically relevant implant-associated hypersensitivity, and positive patch or lymphocyte transformation tests do not by themselves establish causality. Current evidence supports selective, clinically contextualized testing after exclusion of infection and mechanical causes; routine preoperative screening in patients without a suggestive history is not recommended. HLA class II associations and metal–peptide–MHC/T-cell receptor interactions provide a plausible molecular basis for interindividual susceptibility, but available genetic data remain insufficient for clinical risk stratification or implant selection. Future studies should integrate standardized phenotyping, quantitative metal exposure, histopathology, and molecular immune profiling before implementing precision arthroplasty.

16 February 2026 in JEADV Clinical Practice
Verified
Journal Article
Open access
Michał NiedźwiedźMichał Niedźwiedź
Michał Niedźwiedź
JDJulia Domurad‐Falenta
Julia Domurad‐Falenta
MSMałgorzata Skibińska
Małgorzata Skibińska
KPKatarzyna Poznańska‐Kurowska
Katarzyna Poznańska‐Kurowska